Repeated Exposure to Ozone Increases Alveolar Macrophage Recruitment into Asthmatic Airways
Overview
Authors
Affiliations
Rationale: Repeated, short-term exposures to ozone (O3) lead to attenuation of the acute lung function and airway inflammatory responses seen after a single exposure in healthy subjects, but it is unclear whether these acute responses also attenuate in subjects with asthma.
Objective: To address this question by exposing 14 subjects with asthma to 0.2 ppm O3 for either 4 hours on a single day or 4 hours on 4 consecutive days (multiday [MD]). At least 3 weeks later, subjects underwent the alternate exposure.
Methods: Spirometry was performed immediately pre- and postexposure and bronchoalveolar lavage (BAL) was obtained 18 hours after each exposure.
Main Results: The decrease in FEV1 was greatest across Day 2 of the MD (MD2) exposure and then gradually declined on successive days of the MD exposure (mean +/- SD decrease in FEV1 of 25.4 +/- 18.0% across MD2 compared with 4.2 +/- 6.5% across MD4). Respiratory symptoms followed a similar pattern to that of FEV1. Although the concentration of neutrophils in BAL after the MD4 exposure was not significantly different from that after the single-day exposure (1.7 +/- 1.3 x 10(4) cells/ml vs. 1.2 +/- 0.8 x 10(4) cells/ml, p = 0.20), the concentration of alveolar macrophages did significantly increase in BAL after the MD exposure (19.9 +/- 9.7 x 10(4) cells/ml after MD4 vs. 12.1 +/- 6.4 x 10(4) cells/ml after the single day).
Conclusions: Alveolar macrophages are recruited to the airways of subjects with asthma with repeated short-term exposures to O3, suggesting a possible role for these cells in the chronic response to oxidant-induced injury.
The role of the adenylate kinase 5 gene in various diseases and cancer.
Siddiqui M, Shahi M, Castresana J J Clin Transl Sci. 2024; 8(1):e96.
PMID: 39655021 PMC: 11626602. DOI: 10.1017/cts.2024.536.
Abrham Y, Zeng S, Lin W, Lo C, Beckert A, Evans L BMC Pulm Med. 2024; 24(1):433.
PMID: 39223571 PMC: 11367895. DOI: 10.1186/s12890-024-03239-8.
Franzini M, Valdenassi L, Pandolfi S, Tirelli U, Ricevuti G, Chirumbolo S Antioxidants (Basel). 2023; 12(11).
PMID: 38001838 PMC: 10669564. DOI: 10.3390/antiox12111985.
Stapelberg N, Branjerdporn G, Adhikary S, Johnson S, Ashton K, Headrick J Int J Environ Res Public Health. 2022; 19(20).
PMID: 36293807 PMC: 9603079. DOI: 10.3390/ijerph192013226.
Rafiei Hashtchin A, Fehlhaber B, Hetzel M, Manstein F, Stalp J, Glage S Blood Adv. 2021; 5(23):5190-5201.
PMID: 34649271 PMC: 9153022. DOI: 10.1182/bloodadvances.2021004853.